🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The general goal of this study is to investigate the effect of treatment on...
Status
Unknown
Location
University Hospital Tübingen
Start Date
2019-10-01
Trial ID
NCT04122885
Treatments Being Tested
The purpose of this study is to see if there is a difference in survival be...
Status
Completed
Location
Akademiska Sjukhuset (Uppsala University Hospital)
Start Date
2003-06
Trial ID
NCT01524094
To compare outcomes between the CRS group and the control group in patients...
Status
Recruiting
Location
National Cancer Center, Korea
Start Date
2025-09-10
Trial ID
NCT07171528
Treatments Being Tested
This is a genetic disease (transmitted through the parents' genes) called F...
Status
Completed
Location
Children's Hospital Boston
Start Date
2009-09-25
Trial ID
NCT00987480
The main objective of this randomized and controlled trial is to determine ...
Status
Recruiting
Location
Hospital Universitario Reina Sofia
Start Date
2026-05-26
Trial ID
NCT06783491
Treatments Being Tested
This novel study was specifically designed for platinum resistant recurrent...
Status
Withdrawn
Location
Menoufia University, Faculty of medicine
Start Date
2021-04-01
Trial ID
NCT04795596
Treatments Being Tested
Ovarian cancer is the most lethal gynecologic malignancy. The majority of p...
Status
Unknown
Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Start Date
2024-02
Trial ID
NCT06277947
Treatments Being Tested
There is a paucity of data on the histopathological response of peritoneal ...
Status
Unknown
Location
Medical University of Vienna, Department of Internal Medicine I
Start Date
2016-03
Trial ID
NCT02591667
The goal of this clinical research study is to find the highest tolerable d...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-08
Trial ID
NCT03111069
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-07
Trial ID
NCT00027560